Omar El-Agnaf

Процитировано

	Все	Начиная с 2019 г.
Статистика цитирования	22361	12094
h-индекс	74	55
i10-индекс	161	132

2500

1250

625

1875

200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202488 128 110 171 214 215 272 331 454 475 573 669 739 757 876 831 1006 987 1156 1664 1883 2152 2428 2187 1768

Общий доступ

Просмотреть все

54 статьи

7 статей

доступно

недоступно

На основе финансирования

Соавторы

Nour MajbourMRC Prion Unit at UCLПодтвержден адрес электронной почты в домене ucl.ac.uk
Nishant N VaikathQatar Biomedical Resarch Institute, HBKUПодтвержден адрес электронной почты в домене hbku.edu.qa
katerina paleologouDemocritus University of ThraceПодтвержден адрес электронной почты в домене mbg.duth.gr
Brian Austenprofessor of protein science; St George's university of LondonПодтвержден адрес электронной почты в домене sgul.ac.uk
Michael SchlossmacherSenior Scientist, Ottawa Hospital Research InstituteПодтвержден адрес электронной почты в домене ohri.ca
Paolo CalabresiClinica Neurologica, Università di Perugia and IRCCS Fondazione S. Lucia RomaПодтвержден адрес электронной почты в домене unipg.it
Lucilla ParnettiProfessor of Neurology, University of Perugia, Department of Medicine and SurgeryПодтвержден адрес электронной почты в домене unipg.it
Daniel ErskineNewcastle UniversityПодтвержден адрес электронной почты в домене ncl.ac.uk
Wilma van de BergSenior Neuroscientist, associate professorПодтвержден адрес электронной почты в домене amsterdamumc.nl
Tiago Fleming OuteiroUniversity Medical Center Goettingen, Goettingen, GermanyПодтвержден адрес электронной почты в домене gwdg.de
Davide ChiasseriniUniversity of Perugia, Perugia, ItalyПодтвержден адрес электронной почты в домене unipg.it
Paolo EusebiIQVIAПодтвержден адрес электронной почты в домене iqvia.com
Hilal LashuelEPFLПодтвержден адрес электронной почты в домене epfl.ch
Dominic Martin WalshBrigham and Women's HospitalПодтвержден адрес электронной почты в домене bwh.harvard.edu
Ilham AbdiQatar Biomedical Research Institute, Hamad Bin Khalifa UniversityПодтвержден адрес электронной почты в домене hbku.edu.qa
Francis L MartinBlackpool Victoria Teaching Hospitals NHS TrustПодтвержден адрес электронной почты в домене biocel.uk
Ganesh M ShankarHarvard UniversityПодтвержден адрес электронной почты в домене partners.org
kostas vekrellisBIOMEDICAL RESEARCH FOUNDATION ACADEMY OF ATHENS, Research Director, Center forПодтвержден адрес электронной почты в домене bioacademy.gr
Bared Safieh-GarabedianProfessor, College of Medicine, Qatar UniversityПодтвержден адрес электронной почты в домене qu.edu.qa
Henrik ZetterbergSahlgrenskaПодтвержден адрес электронной почты в домене clinchem.gu.se

Omar El-Agnaf

Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation

Подтвержден адрес электронной почты в домене hbku.edu.qa - Главная страница

Alzheimer's disease Parkinson's disease Neuroscience Neurodegenerative diseases protein misfolding


Название По числу цитат По году По названию	Процитировано Процитировано	Год
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium IG McKeith, BF Boeve, DW Dickson, G Halliday, JP Taylor, D Weintraub, ... Neurology 89 (1), 88-100, 2017	3680	2017
Detection of oligomeric forms of α‐synuclein protein in human plasma as a potential biomarker for Parkinson's disease OMA El‐Agnaf, SA Salem, KE Paleologou, MD Curran, MJ Gibson, ... The FASEB journal 20 (3), 419-425, 2006	795	2006
Protein aggregation in the brain: the molecular basis for Alzheimer’s and Parkinson’s diseases GB Irvine, OM El-Agnaf, GM Shankar, DM Walsh Molecular medicine 14, 451-464, 2008	716	2008
α‐Synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma OMA El-Agnaf, SA Salem, KE Paleologou, LJ Cooper, NJ Fullwood, ... The FASEB Journal 17 (13), 1-16, 2003	699	2003
α-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer B Fauvet, MK Mbefo, MB Fares, C Desobry, S Michael, MT Ardah, E Tsika, ... Journal of Biological Chemistry 287 (19), 15345-15364, 2012	671	2012
Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease T Tokuda, MM Qureshi, MT Ardah, S Varghese, SAS Shehab, T Kasai, ... Neurology 75 (20), 1766-1770, 2010	592	2010
CSF and blood biomarkers for Parkinson's disease L Parnetti, L Gaetani, P Eusebi, S Paciotti, O Hansson, O El-Agnaf, ... The Lancet Neurology 18 (6), 573-586, 2019	533	2019
Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson’s disease T Tokuda, SA Salem, D Allsop, T Mizuno, M Nakagawa, MM Qureshi, ... Biochemical and biophysical research communications 349 (1), 162-166, 2006	509	2006
Aggregates from mutant and wild-type α-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of β-sheet and amyloid-like … OMA El-Agnaf, R Jakes, MD Curran, D Middleton, R Ingenito, E Bianchi, ... FEBS letters 440 (1-2), 71-75, 1998	495	1998
Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration B Mollenhauer, V Cullen, I Kahn, B Krastins, TF Outeiro, I Pepivani, J Ng, ... Experimental neurology 213 (2), 315-325, 2008	451	2008
Certain inhibitors of synthetic amyloid β-peptide (Aβ) fibrillogenesis block oligomerization of natural Aβ and thereby rescue long-term potentiation DM Walsh, M Townsend, MB Podlisny, GM Shankar, JV Fadeeva, ... Journal of Neuroscience 25 (10), 2455-2462, 2005	406	2005
Court JA, Schlossmacher MG, Allsop D. Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson’s disease OM El-Agnaf, SA Salem, KE Paleologou, MD Curran, MJ Gibson Faseb j 20 (3), 419-425, 2006	382	2006
Formation of hydrogen peroxide and hydroxyl radicals from Aβ and α-synuclein as a possible mechanism of cell death in Alzheimer’s disease and Parkinson’s disease BJ Tabner, S Turnbull, OMA El-Agnaf, D Allsop Free Radical Biology and Medicine 32 (11), 1076-1083, 2002	353	2002
Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of α-synuclein protein implicated in Parkinson's disease OMA El-Agnaf, R Jakes, MD Curran, A Wallace FEBS letters 440 (1-2), 67-70, 1998	352	1998
Hydrogen peroxide is generated during the very early stages of aggregation of the amyloid peptides implicated in Alzheimer disease and familial British dementia BJ Tabner, OMA El-Agnaf, S Turnbull, MJ German, KE Paleologou, ... Journal of Biological Chemistry 280 (43), 35789-35792, 2005	296	2005
Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease NK Majbour, NN Vaikath, KD Van Dijk, MT Ardah, S Varghese, ... Molecular neurodegeneration 11, 1-15, 2016	269	2016
Oligomerization and toxicity of β-amyloid-42 implicated in Alzheimer's disease OMA El-Agnaf, DS Mahil, BP Patel, BM Austen Biochemical and biophysical research communications 273 (3), 1003-1007, 2000	269	2000
Cerebrospinal fluid lysosomal enzymes and alpha‐synuclein in Parkinson's disease L Parnetti, D Chiasserini, E Persichetti, P Eusebi, S Varghese, ... Movement Disorders 29 (8), 1019-1027, 2014	265	2014
Detection of elevated levels of soluble α-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies KE Paleologou, CL Kragh, DMA Mann, SA Salem, R Al-Shami, D Allsop, ... Brain 132 (4), 1093-1101, 2009	257	2009
Cerebrospinal fluid biomarkers in Parkinson disease L Parnetti, A Castrioto, D Chiasserini, E Persichetti, N Tambasco, ... Nature Reviews Neurology 9 (3), 131-140, 2013	256	2013

В данный момент система не может выполнить эту операцию. Повторите попытку позднее.

Статьи 1–20

Ссылок за год

Повторяющиеся цитирования

Объединенные цитирования

СоавторыСоавторы

Подписаться

Процитировано

Соавторы